An official website of the United States government
These tables are also available in a printable version (PDF, 626 KB).
Comprehensive ICD-10 Casefinding "Must Collect" Code List for Reportable Tumors (Effective Date: 1/1/2011)
| ICD-10 Code^ | Explanation of Code |
|---|---|
| B21._ | Human Immunodeficiency virus [HIV] disease with malignant neoplasms |
| C00._ – C97._ | Malignant neoplasms |
| D00._ – D09._ | In-situ neoplasms |
| D18.0 | Hemangioma, any site Note: This category includes Hemangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable. |
| D18.1 | Lymphangioma, any site Note: This category includes Lymphangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable. |
| D32._ | Benign neoplasm of meninges (cerebral, spinal and unspecified) |
| D33._ | Benign neoplasm of brain and other parts of central nervous system |
| D35.2 | Benign neoplasm of pituitary gland |
| D35.3 | Benign neoplasm of craniopharyngeal duct |
| D35.4 | Benign neoplasm of pineal gland |
| D39.0 | Neoplasm of uncertain behavior uterus (Endometrial stroma, low grade 8931/1 or 8931/3) |
| D42._ | Neoplasm of uncertain or unknown behavior of meninges |
| D43._ | Neoplasm of uncertain or unknown behavior of brain and central nervous system |
| D44.3 – D44.5 | Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland |
| D45 | Polycythemia vera (9950/3) |
| D46.0 | Refractory anemia without sideroblasts, so stated (9991/3, 9992/3) |
| D46.1 | Refractory anemia with sideroblasts (9982/3) |
| D46.2 | Refractory anemia with excess of blasts (9983/3) |
| D46.3 | Refractory anemia with excess blasts in transformation (9984/3) |
| D46.4 | Refractory anemia, unspecified (9980/3) |
| D46.7 | Other myelodysplastic syndromes (9985/3, 9986/3) |
| D46.9 | Myelodysplastic syndrome, unspecified (9989/3) |
| D47.1 | Chronic myeloproliferative disease (9960/3, 9961/3) |
| D47.3 | Esssential (hemorrhagic) thrombocythemia (9962/3) |
| D47.7 | Other specified neoplasms of uncertain/unknown behavior of lymphoid, hematopoietic (9759/3, 9965/3, 9966/3, 9967/3, 9971/3, 9987/3) |
| D47.9 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9960/3, 9961/3, 9970/1, 9931/3) |
| D48.9 | Neoplasm of uncertain or unknown behavior, unspecified Note: This category includes uncertain or unknown behavior of Brain, Other parts of nervous system and endocrine glands, which are reportable. |
| D76.0 | Langerhans cell histiocytosis, not elsewhere classified (9751/3, 9754/3) |
| D89.1 | Cryoglobulinemia (9762/3) |
NOTE: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic, and other reportable neoplasms.
Supplementary ICD-10 Casefinding "Can Collect" Code List for Reportable Tumors (Effective Date: 1/1/2011)
| ICD-10 Code^ | Explanation of Code |
|---|---|
| B20._ | Human immunodeficiency virus [HIV] disease with infectious and parasitic diseases |
| B22._ | Human immunodeficiency virus [HIV] disease with other specified diseases |
| B23._ | Human immunodeficiency virus [HIV] disease with other conditions |
| B24._ | Unspecified human immunodeficiency virus [HIV] virus |
| B99 | Other infectious diseases (Human papillomavirus, Retrovirus-HTLV types I, II and 2) |
| D10._ – D31._, D34._, D35._, D35.1, D35.5 – D35.8, D35.9, D36._ | Benign neoplasms (see "must collect" list for reportable benign neoplasms) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
| D37._ – D38._, D39.1 – D39.9, D40._ – D41._ | Neoplasms of uncertain or unknown behavior (see "must collect" list for reportable neoplasms of uncertain or unknown behavior) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
| D44.0 – D44.2, D44.6 – D44.9 | Neoplasm of uncertain or unknown behavior of other endocrine glands (see reportable list for D44.3-D44.5) |
| D47.0 | Histiocytic and mast cell tumors of uncertain behavior |
| D47.2 | Monoclonal gammopathy Note: Screen for incorrectly coded Waldenstrom’s macroglobulinemia |
| D48.0 – D48.7 | Neoplasms of uncertain or unknown behavior |
| D60._ | Acquired pure red cell aplasia [erythroblastopenia] |
| D61.1 – D61.9 | Other aplastic anemias Note: Review for miscodes |
| D64._ | Other anemias |
| D70 | Agranulocytosis |
| D72.1 | Eosinophilia Note: This is the code for eosinophilia (9964/3). Not every case of eosinophilia is associated with a malignancy. Diagnosis must be "Hypereosonophilic syndrome" to be reportable. |
| D75.0 | Familial erythrocytosis (familial polycythemia) Note: This is a symptom of polycythemia vera. |
| D75.8 | Other specified diseases of blood and blood forming organs Note: This is the code for myelofibrosis (NOS) (9961/3). Not every case of myelofibrosis is associated with a malignancy. Review terms included in ICD-O-3 to determine if case is reportable. |
| D76.1 – D76.3._ | Certain diseases involving lymphoreticular tissue and reticulohistiocytic system |
| D80.0 | Hereditary hypogammaglobulinemia Note: Predisposed to lymphoma or stomach cancer |
| D80.1 | Nonfamilial hypogammaglobulinemia Note: Associated with lymphoproliferative disorders |
| D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses Note: Associated with lymphoproliferative disorders |
| D80.4 | Selective deficiency of immunoglobulin M [IgM] Note: Associated with lymphoproliferative disorders |
| D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] Note: Associated with lymphoproliferative disorders |
| D81.0 | Severe combined immunodeficiency [SCID] with reticular dysgenesis |
| D81.1 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers |
| D81.2 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers |
| D81.4 | Nezelof's syndrome |
| D81.6 – D81.7 | Major histocompatibility complex class I and class II deficiency |
| D81.8 | Other combined immunodeficiencies |
| D81.9 | Combined immunodeficiency, unspecified |
| D82.0 | Wiskott-Aldrich syndrome |
| D83._ | Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
| D84.1 | Defects in the complement system |
| D84.9 | Immunodeficiency, unspecified |
| D89._ | Other disorders involving the immune mechanism, not elsewhere classified Note: Review for miscodes |
| E22.2 | Syndrome of inappropriate secretion of antidiuretic hormone Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| E30.8 | Other disorders of puberty |
| E31.9 | Polyglandular dysfunction, unspecified Note: This is the code for "multiple endocrine neoplasia (MEN) type IIA and IIB (rare familial cancer syndrome)" |
| E34.0 | Carcinoid syndrome |
| E34.1 | Other hypersecretion of intestinal hormones |
| E34.8 | Other specified endocrine disorders |
| E83.5 | Disorders of calcium metabolism Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| E88.0 | Disorders of plasma-protein metabolism, not elsewhere classified Note: Screen for incorrectly coded Waldenstrom’s macroglobulinemia |
| E88.8 | Other specified metabolic disorders |
| E88.9 | Metabolic disorder, unspecified |
| G04.8 | Other encephalitis, myelitis, and encephalomyelitis Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| H55 | Nystagmus and other irregular eye movements Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| J90 | Pleural effusion, not elsewhere classified Note: This is the code for "malignant pleural effusion" |
| K12.1 | Other forms of stomatitis Note: This is the code for "Mucositis due to antineoplastic therapy" |
| K31.7 | Polyp of stomach and duodenum |
| L30.4 | Erythrema intertrigo Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| L53.8 | Other specified erythematous conditions Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| L83 | Acanthosis nigricans Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| L88 | Pyoderma gangrenosum Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| M33.2 | Polymyositis Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| M33.9 | Dermatopolymyositis, unspecified Note: Part of the paraneoplastic syndrome. See note of explanation in the "notes" section |
| M35.9 | Systemic involvement of connective tissue, unspecified |
| M84.4 | Pathologic fracture, not elsewhere classified Note: Fracture due to neoplasm |
| O01._ | Hydatidiform mole Note: This is a benign tumor that can become malignant. If malignant, it should be reported as Choriocarcinoma (9100/3) and will have a malignancy code in the C00- C97 range |
| Q85.0 | Neurofibromatosis (nonmalignant) (9540/1) |
| Q90._ | Down's syndrome Note: Screen for myeloid leukemia associated with Down's Syndrome (9898/3) |
| R18 | Ascites Note: This is the code for "malignant ascites" |
| R52.9 | Pain, unspecified Note: This is the code for "neoplasm related pain (acute, chronic); Cancer associated pain; Pain due to malignancy (primary/secondary); Tumor associated pain" |
| R59._ | Enlarged lymph nodes Note: Screen for large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease (9738/3) |
| R85.6 | Abnormal findings in specimens from digestive organs and abdominal cavity, abnormal cytological findings |
| R87.6 | Abnormal findings in specimens from female genital organs, abnormal cytological findings. |
| T45.1 | Poisoning by antineoplastic and immunosuppressive drugs Mote: Adverse reaction of antineoplastic therapy or immunosuppressive drugs |
| T66 | Unspecified effects of radiation Note: Adverse reaction of radiation therapy |
| T80.2 | Infections following infusion, transfusion, and therapeutic injection Note: Infection due to central venous catheter (porta-cath) |
| T80.8 | Other complications following infusion, transfusion, and therapeutic injection Note: Extravasation of vesicant chemotherapy |
| Y43.1 – Y43.3 | Adverse effects in therapeutic use, antineoplastic products or drugs |
| Y63.2 | Failure in dosage, overdose of radiation given during therapy |
| Y84.2 | Abnormal reaction, radiological procedure and radiotherapy |
NOTES:
- Prostatic Intraepithelial Neoplasia (PIN III) M-8148/2 is not required by SEER.
- Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior a /3 (malignant).
- Borderline cystadenomas M-8442, 8451, 8462, 8472, 8473, of the ovaries moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. SEER registries are not required to collect these cases for diagnoses made 1/1/2001 and after. However, cases diagnosed prior to 1/1/2001 should still be abstracted and reported to SEER.
- Codes E22.2, E83.5, G04.8, H55, L30.4, L53.8, L83, L88, M33.2 and M33.9 are part of the paraneoplastic syndrome. "Paraneoplastic syndrome isn't cancer. It's a disease or symptom that is the consequence of cancer but is not due to the local presence of cancer cells. A paraneoplastic syndrome may be the first sign of cancer."
^ World Health Organization. International Statistical Classification of Diseases and Related Health problems, Tenth Revision. Geneva: World Health Organization. 2007
